| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.029 | 0.8 |